These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28705617)

  • 41. The influence on the oral bioavailability of solubilized and suspended drug in a lipid nanoparticle formulation: In vitro and in vivo evaluation.
    Elbrink K; Van Hees S; Roelant D; Loomans T; Holm R; Kiekens F
    Eur J Pharm Biopharm; 2022 Oct; 179():1-10. PubMed ID: 36031014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs.
    Yasmin R; Rao S; Bremmell K; Prestidge C
    Eur J Pharm Sci; 2017 Jan; 96():508-514. PubMed ID: 27793717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-component solid lipid nanocarriers prepared with ultra-long chain amphiphilic lipids.
    Wei W; Lu X; Wang Z; Pérez B; Liu J; Wu C; Dong M; Feng F; Mu H; Guo Z
    J Colloid Interface Sci; 2017 Nov; 505():392-401. PubMed ID: 28623698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
    Teixeira MC; Carbone C; Souto EB
    Prog Lipid Res; 2017 Oct; 68():1-11. PubMed ID: 28778472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.
    Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S
    J Pharm Pharmacol; 2011 Jun; 63(6):774-9. PubMed ID: 21585374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs.
    Yasmin R; Rao S; Bremmell KE; Prestidge CA
    AAPS J; 2016 Jul; 18(4):876-85. PubMed ID: 27048207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
    Shah RM; Eldridge DS; Palombo EA; Harding IH
    Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tools for Early Prediction of Drug Loading in Lipid-Based Formulations.
    Alskär LC; Porter CJ; Bergström CA
    Mol Pharm; 2016 Jan; 13(1):251-61. PubMed ID: 26568134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
    Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
    Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
    Kumar S; Randhawa JK
    Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nano lipid-drug conjugate: An integrated review.
    Adhikari P; Pal P; Das AK; Ray S; Bhattacharjee A; Mazumder B
    Int J Pharm; 2017 Aug; 529(1-2):629-641. PubMed ID: 28723407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
    Azad M; Moreno J; Bilgili E; Davé R
    Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption.
    Yang L; Shao Y; Han HK
    Int J Nanomedicine; 2016; 11():1067-76. PubMed ID: 27042061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
    Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
    Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.